CryoPort (NASDAQ:CYRX) CFO Sells 38,700 Shares

CryoPort, Inc. (NASDAQ:CYRX) CFO Robert Stefanovich sold 38,700 shares of the business’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $7.76, for a total transaction of $300,312.00. Following the sale, the chief financial officer owned 255,701 shares of the company’s stock, valued at $1,984,239.76. This represents a 13.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Robert Stefanovich also recently made the following trade(s):

• On Monday, March 16th, Robert Stefanovich sold 2,743 shares of CryoPort stock. The stock was sold at an average price of $8.00, for a total transaction of $21,944.00.

CryoPort Stock Up 2.3%

CYRX traded up $0.18 on Monday, reaching $8.00. The company had a trading volume of 578,199 shares, compared to its average volume of 400,853. CryoPort, Inc. has a 1 year low of $4.63 and a 1 year high of $11.45. The stock has a market capitalization of $398.88 million, a PE ratio of 6.06 and a beta of 1.69. The stock has a 50-day moving average price of $9.23 and a 200-day moving average price of $9.36.

CryoPort (NASDAQ:CYRX) last posted its earnings results on Tuesday, March 3rd. The company reported ($0.21) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.02). CryoPort had a negative return on equity of 8.22% and a net margin of 42.35%.The firm had revenue of $45.45 million for the quarter, compared to analyst estimates of $42.92 million. As a group, analysts expect that CryoPort, Inc. will post -0.99 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on CYRX shares. Needham & Company LLC boosted their price objective on CryoPort from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Wednesday, March 4th. Wall Street Zen downgraded shares of CryoPort from a “hold” rating to a “sell” rating in a research report on Saturday, March 7th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of CryoPort in a research note on Monday, December 29th. Eight equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $12.94.

Hedge Funds Weigh In On CryoPort

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Basepoint Wealth LLC acquired a new position in CryoPort in the 4th quarter valued at $34,000. Tower Research Capital LLC TRC boosted its holdings in shares of CryoPort by 300.1% in the second quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after acquiring an additional 4,375 shares in the last quarter. Whittier Trust Co. of Nevada Inc. purchased a new stake in shares of CryoPort in the third quarter valued at about $53,000. ProShare Advisors LLC acquired a new position in shares of CryoPort during the second quarter worth about $75,000. Finally, AlphaQuest LLC purchased a new position in CryoPort during the third quarter worth about $79,000. 92.90% of the stock is currently owned by hedge funds and other institutional investors.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.